The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis

Multiple myeloma (MM) is a plasma cell malignancy comprising 10% of hematologic cancers, associated with bone marrow dysfunction and organ damage. High-risk cytogenetic MM patients, identified by specific genetic abnormalities, face poor outcomes despite recent advancements. Traditional treatments o...

Full description

Bibliographic Details

Published in:	Frontiers in medicine Vol. 12; p. 1575914
Main Authors:	Zhou, Huixing, Chen, Wenming
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 13.05.2025
Subjects:	CD38 antibodies high-risk cytogenetics Medicine minimal residual disease multiple myeloma novel drug regimens progression-free survival multiple myeloma novel drug regimens progression-free survival CD38 antibodies meta-analysis minimal residual disease systematic review high-risk cytogenetics
ISSN:	2296-858X, 2296-858X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!